268 related articles for article (PubMed ID: 15475406)
1. Fluoroquinolones in multidrug-resistant tuberculosis.
Mohapatra PR
Am J Respir Crit Care Med; 2004 Oct; 170(8):920-1. PubMed ID: 15475406
[No Abstract] [Full Text] [Related]
2. Direct observation therapy-plus can prevent acquired resistance to fluoroquinolones among patients with multidrug-resistant tuberculosis in Taiwan.
Chien JY; Lai CC; Tan CK; Yu CJ; Hsueh PR
Clin Infect Dis; 2013 Apr; 56(7):1054-5. PubMed ID: 23175554
[No Abstract] [Full Text] [Related]
3. State of the Art series on drug-resistant tuberculosis: it's time to protect fluoroquinolones.
Chiang CY
Int J Tuberc Lung Dis; 2009 Nov; 13(11):1319. PubMed ID: 19861001
[No Abstract] [Full Text] [Related]
4. Fluoroquinolones resistance in multidrug-resistant tuberculosis in Pakistan and suitability of guidelines recommended standardized regimen.
Ahmad N; Khan AH; Syed Sulaiman SA; Javaid A
Int J Mycobacteriol; 2015 Sep; 4(3):258-9. PubMed ID: 27649876
[No Abstract] [Full Text] [Related]
5. [Respiratory fluoroquinolones and pulmonary tuberculosis treatment when the main drugs are ineffective].
Lazareva NB; Khaĭmenova TIu; Khaĭmenov AIa
Antibiot Khimioter; 2008; 53(5-6):14-20. PubMed ID: 19069177
[No Abstract] [Full Text] [Related]
6. How are we creating fluoroquinolone-resistant tuberculosis?
Bernardo J; Yew WW
Am J Respir Crit Care Med; 2009 Aug; 180(4):288-9. PubMed ID: 19661251
[No Abstract] [Full Text] [Related]
7. Multidrug-resistant tuberculosis (TB) resistant to fluoroquinolones and streptomycin but susceptible to second-line injection therapy has a better prognosis than extensively drug-resistant TB.
Chan ED; Strand MJ; Iseman MD
Clin Infect Dis; 2009 Mar; 48(5):e50-2. PubMed ID: 19191632
[TBL] [Abstract][Full Text] [Related]
8. In reply.
Takiff H; Alame-Emane AK; Pierre-Audigier C; Gicquel B
Int J Tuberc Lung Dis; 2016 Feb; 20(2):282-3. PubMed ID: 26792487
[No Abstract] [Full Text] [Related]
9. Fluoroquinolone and pyrazinamide resistance in multidrug-resistant tuberculosis.
Pierre-Audigier C; Surcouf C; Cadet-Daniel V; Namouchi A; Heng S; Murray A; Guillard B; Gicquel B
Int J Tuberc Lung Dis; 2012 Feb; 16(2):221-3, i-ii. PubMed ID: 22236923
[TBL] [Abstract][Full Text] [Related]
10. No evidence that pyrazinamide resistance is acquired after fluoroquinolone resistance.
Cobelens F; Gebhard A; van den Hof S
Int J Tuberc Lung Dis; 2016 Feb; 20(2):282. PubMed ID: 26792486
[No Abstract] [Full Text] [Related]
11. [Floracide, a Russian 3rd generation fluoroquinolone in complex therapy of tuberculosis].
Sokolova GB; Kirtaeva OV; Lazareva IaV; Tsybanev AA
Antibiot Khimioter; 2008; 53(5-6):28-31. PubMed ID: 19069179
[No Abstract] [Full Text] [Related]
12. Fluoroquinolone resistance in Mycobacterium tuberculosis. What have we learnt?
Yew WW; Lange C
Int J Tuberc Lung Dis; 2014 Jan; 18(1):1-2. PubMed ID: 24365543
[No Abstract] [Full Text] [Related]
13. [Sparfloxacin in combined therapy for pulmonary tuberculosis].
Sokolova GB; Khaĭmenova TIu; Lazareva IaV; Khaĭmenov AIa
Antibiot Khimioter; 2008; 53(5-6):21-7. PubMed ID: 19069178
[TBL] [Abstract][Full Text] [Related]
14. Changing epidemiology of respiratory pathogens and the role of improved diagnostics.
Kotsimbos T; Cheng AC
Respirology; 2011 Aug; 16(6):873-5. PubMed ID: 21627716
[No Abstract] [Full Text] [Related]
15. [Reasons for drug-resistant tuberculosis emergence].
Tu DH
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):403-5. PubMed ID: 17673006
[No Abstract] [Full Text] [Related]
16. [Comparative efficiency of treatment with moxyfloxacin and lomefloxacin for generalized murine tuberculosis caused by drug-resistant Mycobacterium strains].
Mozhokina GN; Sokolova GB; Dashieva DG; Mikhaĭlova LP; Elistratova NA
Probl Tuberk Bolezn Legk; 2005; (2):19-22. PubMed ID: 15881962
[TBL] [Abstract][Full Text] [Related]
17. Risk factors associated with fluoroquinolone-resistant tuberculosis in a Beijing tuberculosis referral hospital.
Liu CH; Yang N; Wang Q; Hu YL; Li L; Zhang GY; Zhu B
Respirology; 2011 Aug; 16(6):918-25. PubMed ID: 21564401
[TBL] [Abstract][Full Text] [Related]
18. [Treatment outcomes of multidrug-resistant tuberculosis--comparison between success and failure cases].
Shigetoh E; Murakami I; Yokosaki Y; Kurimoto N
Kekkaku; 2001 Dec; 76(12):723-8. PubMed ID: 11806128
[TBL] [Abstract][Full Text] [Related]
19. The role of surgery and fluoroquinolones in the treatment of multidrug-resistant tuberculosis.
Törün T; Tahaoğlu K; Ozmen I; Sevim T; Ataç G; Kir A; Güngör G; Bölükbaşi Y; Maden E
Int J Tuberc Lung Dis; 2007 Sep; 11(9):979-85. PubMed ID: 17705975
[TBL] [Abstract][Full Text] [Related]
20. Linezolid in the treatment of drug-resistant tuberculosis: the way forward?
Yew WW; Lange C
Int J Tuberc Lung Dis; 2014 Jun; 18(6):631-2. PubMed ID: 24903928
[No Abstract] [Full Text] [Related]
[Next] [New Search]
